Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 4, 2011, Pages 883-891

  Bellasi, Antonio ^a   Mandreoli, Marcora ^a   Baldrati, Leopoldo ^b   Malmusi, Matteo Corradini ^c   Di Nicolo, Pierpaolo ^d   Malmusi, Giulio ^e   Santoro, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BUFALINI HOSPITAL   (Italy)

^c Arcispedale SMaria Nuovo   (Italy)

^d Ospedale Nuovo   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; PHOSPHORUS;

AGE; AGED; ARTICLE; AWARENESS; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIALYSIS; DISEASE COURSE; DYING; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPHOSPHATEMIA; ITALY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROLOGIST; OUTCOME ASSESSMENT; PATIENT CARE; PHOSPHATE BLOOD LEVEL; SEX;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PHOSPHORUS;

EID: 79955555142     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07810910     Document Type: Article

References (31)

1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31: 607-617, 1998
2. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
3. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpat-rick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
4. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005
5. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885, 2007
6. Onufrak SJ, Bellasi A, Cardarelli F, Vaccarino V, Muntner P, Shaw LJ, Raggi P: Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am J Epidemiol 169: 67-77, 2009
7. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005
8. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA: Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20: 397-404, 2009
9. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijp-kens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW: High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22: 2909-2916, 2007
10. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73: 1296-1302, 2008
11. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP: Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1: 825-831, 2006
12. Norris KC, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A, Rostand S, Wang X, Appel LJ: Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 17: 2928-2936, 2006
13. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol 73: 268-275, 2010
14. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 46: 455-463, 2005
15. Onufrak SJ, Bellasi A, Shaw LJ, Herzog CA, Cardarelli F, Wilson PW, Vaccarino V, Raggi P: Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 199: 424-431, 2008
16. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hen-driksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006
17. Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ: Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 20: 2625-2630, 2009
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
19. Cox DR, OD: Analysis of survival data (ed1). New York NY, Chapman and Hall, 1990
20. Chen CH, George SL: The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. Stat Med 4: 39-46, 1985
21. Sauerbrei W, Schumacher M: A bootstrap resampling procedure for model building: Application to the Cox regression model. Stat Med 11: 2093-2109, 1992
22. Foley RN, Wang C, Collins AJ: Cardiovascular risk factor profiles and kidney function stage in the US general population: The NHANES III study. Mayo Clin Proc 80: 1270-1277, 2005
23. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36: 646-661, 2000
24. Quarles LD: Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118: 3820-3828, 2008
25. Berndt TJ, Schiavi S, Kumar R: "Phosphatonins" and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol 289: F1170-F1182, 2005
26. Carrillo-Lopez N, Roman-Garcia P, Rodriguez-Rebollar A, Fernandez-Martin JL, Naves-Diaz M, Cannata-Andia JB: Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol 20: 2009-2017, 2009
27. Cirillo M, Ciacci C, De Santo NG: Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 359: 864-866, 2008
28. Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD: Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 5: 683-692, 2010
29. Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Na-gasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H: The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone 45: 949-955, 2009
30. London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18: 613-620, 2007
31. Schumock GT, Andress DL, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K: Association of secondary hyperparathy-roidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract 113: c54-c61, 2009